PHIBRO ANIMAL HEALTH CORP (PAHC) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — PAHC

Balance Sheet

(in billions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	0.05	0.06	0.07	0.06	0.07	0.05	0.05	0.03	0.04	0.04	0.07	0.08	0.07	0.06	0.04	0.05	0.03	0.03
Short-term Investments	0.02	0.02	0.01	0.01	0.00	0.04	0.05	0.06	0.05	0.04	0.01	0.01	0.02	0.03	0.06	0.04	0.06	0.06
Accounts Receivable	0.22	0.22	0.22	0.20	0.19	0.16	0.16	0.15	0.15	0.15	0.15	0.14	0.16	0.14	0.14	0.14	0.13	0.13
Inventory	0.54	0.52	0.47	0.45	0.43	0.27	0.28	0.29	0.28	0.29	0.29	0.28	0.25	0.23	0.22	0.21	0.21	0.21
Total Current Assets	0.89	0.86	0.84	0.78	0.75	0.57	0.60	0.59	0.58	0.59	0.58	0.57	0.55	0.51	0.50	0.47	0.48	0.46
Property, Plant & Equipment	0.36	0.36	0.35	0.34	0.34	0.21	0.20	0.20	0.19	0.19	0.19	0.18	0.16	0.15	0.15	0.15	0.15	0.15
Goodwill	0.06	0.06	0.06	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Intangible Assets	0.03	0.03	0.03	0.04	0.04	0.04	0.05	0.05	0.05	0.06	0.06	0.06	0.07	0.06	0.06	0.06	0.07	0.07
Total Non-current Assets*	0.55	0.54	0.55	0.54	0.54	0.40	0.38	0.39	0.38	0.38	0.38	0.38	0.37	0.34	0.34	0.33	0.33	0.33
Total Assets	1.45	1.41	1.39	1.32	1.29	0.97	0.98	0.97	0.96	0.97	0.96	0.95	0.92	0.85	0.84	0.81	0.80	0.79
Accounts Payable	0.13	0.13	0.13	0.13	0.10	0.09	0.08	0.09	0.08	0.08	0.08	0.09	0.09	0.08	0.07	0.06	0.06	0.06
Short-term Debt	--	--	--	--	--	--	0.03	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	0.28	0.28	0.27	0.27	0.23	0.18	0.19	0.19	0.17	0.17	0.17	0.17	0.19	0.17	0.15	0.17	0.17	0.16
Long-term Debt	0.62	0.62	0.63	0.64	0.64	0.30	0.29	0.32	0.33	0.29	0.29	0.30	0.29	0.29	0.30	0.20	0.21	0.21
Total Non-current Liabilities*	0.80	0.79	0.80	0.78	0.81	0.53	0.52	0.51	0.52	0.53	0.53	0.51	0.46	0.44	0.45	0.42	0.42	0.44
Total Liabilities	1.08	1.07	1.07	1.05	1.04	0.71	0.71	0.70	0.69	0.69	0.69	0.69	0.65	0.61	0.60	0.59	0.59	0.60
Retained Earnings	0.34	0.32	0.29	0.26	0.24	0.25	0.25	0.24	0.25	0.25	0.25	0.25	0.25	0.23	0.22	0.21	0.20	0.19
Total Stockholder Equity	0.36	0.33	0.31	0.27	0.25	0.26	0.27	0.27	0.27	0.27	0.27	0.26	0.27	0.24	0.23	0.22	0.21	0.19

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Total Revenue	396.75	383.54	373.91	363.89	378.70	347.83	309.26	260.43	273.16	263.22	249.94	231.35	255.05	245.67	244.65	232.52	255.27	239.62	232.71	214.67
Cost of Revenue	262.35	257.87	241.25	244.11	268.69	243.26	207.39	176.94	186.01	183.62	171.33	163.62	178.38	170.13	167.26	163.88	176.84	167.99	162.04	149.99
Gross Profit	134.40	125.68	132.66	119.78	110.01	104.57	101.87	83.50	87.15	79.60	78.62	67.73	76.67	75.54	77.39	68.65	78.42	71.63	70.67	64.68
Selling, General & Admin	86.24	81.02	82.33	68.52	76.29	71.05	76.34	65.80	68.73	59.68	62.92	68.45	52.90	56.99	61.54	54.96	55.54	52.43	48.38	50.07
Total Operating Expenses*	86.24	81.02	82.33	68.52	76.29	71.05	76.34	65.80	68.73	59.68	62.92	68.45	52.90	56.99	61.54	54.96	55.54	52.43	48.38	50.07
Operating Income	48.16	44.65	50.33	51.26	33.72	33.52	25.53	17.70	18.42	19.92	15.70	(0.73)	23.77	18.55	15.84	13.68	22.89	19.19	22.29	14.61
Interest Expense	--	--	--	--	--	--	--	--	--	5.65	5.72	5.65	5.45	4.91	4.63	3.70	3.41	3.11	3.10	3.07
Pretax Income	32.34	32.31	36.42	36.27	23.85	29.69	4.84	9.62	6.41	12.92	3.57	(11.98)	21.44	15.10	12.11	5.42	12.37	26.83	23.53	9.60
Tax Provision	10.63	8.29	8.97	9.74	6.62	8.81	1.65	2.65	5.66	4.52	2.29	(3.96)	9.94	5.06	4.90	1.56	4.88	9.14	6.07	3.06
Net Income	21.71	24.02	27.46	26.53	17.22	20.88	3.19	6.98	0.75	8.40	1.27	(8.01)	11.50	10.04	7.21	3.86	7.49	17.69	17.47	6.53
Basic EPS	--	0.59	0.68	0.65	0.42	0.52	0.08	0.17	0.02	0.21	0.03	(0.20)	0.28	0.25	0.18	0.10	0.18	0.44	0.43	0.16
Diluted EPS	--	0.59	0.67	0.65	0.43	0.51	0.08	0.17	0.02	0.21	0.03	(0.20)	0.28	0.25	0.18	0.10	0.18	0.44	0.43	0.16

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Operating Cash Flow	24.09	16.21	19.35	9.30	21.27	43.15	3.08	12.62	28.43	11.41	31.56	16.20	20.24	6.26	(2.49)	(10.70)	1.57	6.13	20.12	3.82
Capital Expenditures	18.87	15.32	11.10	13.81	13.14	7.75	7.82	9.58	13.07	9.73	10.96	7.48	10.89	7.91	9.82	23.18	11.89	10.02	7.69	7.45
Free Cash Flow*	5.23	0.89	8.26	(4.50)	8.13	35.41	(4.75)	3.04	15.36	1.68	20.60	8.72	9.35	(1.65)	(12.31)	(33.87)	(10.32)	(3.88)	12.43	(3.63)
Investing Cash Flow	(16.45)	(16.81)	(17.18)	(21.01)	(7.03)	(18.25)	(260.47)	(2.93)	(9.11)	1.13	(24.86)	(15.35)	(10.28)	(37.78)	(9.81)	(16.15)	(9.54)	(9.94)	17.57	(20.67)
Financing Cash Flow	(1.61)	(2.30)	(18.98)	16.34	(7.77)	(32.22)	276.32	(29.20)	1.79	4.85	(14.70)	1.30	(6.33)	0.28	3.72	29.32	12.39	10.27	(14.58)	8.27

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Dividends Per Share	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12